English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > ドラッグデリバリー > 欧州のドラッグデリバリー市場 - 機会分析
カテゴリ
医薬品 (4964)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1524)
糖尿病 (193)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

欧州のドラッグデリバリー市場 - 機会分析

European Drug Delivery Markets - Opportunity Analysis

発行 Frost & Sullivan
出版日 2008年06月 商品コード 69888
ページ情報 英文  
価格
US$ 6,500 換算 ¥ 523,055 (税抜) Web Access (Regional License)
US$ 7,000 換算 ¥ 563,290 (税抜) Hard Copy & Web Access (Regional License)


原文目次

Abstract

The research services deals with the a strategic insight in to the opportunity in the drug delivery markets especially pulmonary and transdermal segments in Europe. Market drivers, restraints, industry challenges, key trends, revenue forecasts and strategic recommendations are provided in detail.

Table of Contents

1. EXECUTIVE SUMMARY

Overview of the European Drug Delivery Market

  • Summary of the European Drug Delivery Market

2. INTRODUCTION

Research Methodology

  • Methodology
  • Scope and Objectives

3. DRUG DELIVERY MARKET - OPPORTUNITY ANALYSIS

Opportunity Analysis

  • Introduction
  • Industry Challenges
  • Market Analysis

4. MARKET ENGINEERING RESEARCH FOR PULMONARY DRUG DELIVERY

Market Engineering Research

  • Market Overview
  • Market Engineering Measurements
  • Market Drivers
  • Market Restraints
  • Competitive Structure
  • Revenue Forecasts

5. MARKET ENGINEERING RESEARCH FOR TRANSDERMAL DRUG DELIVERY

Market Engineering Research

  • Market Overview
  • Market Engineering Measurements
  • Market Drivers
  • Market Restraints
  • Competitive Structure
  • Revenue Forecasts

6. NANOTECHNOLOGY DRUG DELIVERY

Overview of the European Nanotechnology Drug Delivery Market

  • Snapshot of the Nanotechnology Market

7. STRATEGIC RECOMMENDATIONS

Strategic Recommendations for the European Drug Delivery Market

  • Market Engineering Recommendations

8. DATABASE OF KEY INDUSTRY PARTICIPANTS

Key Participants

  • Major Industry Participants

9. APPENDIX

Decision Support Database Tables

  • Asthma Prevalence
  • COPD Prevalence
  • Biotech Companies
  • Private Investment in Biotechnology
Back to Top